Silent Rapid Eye Movements Marc Farssac, CEO Berlin, 19. March 2015 www.snoreware.com • MARC.FARSSAC@SNOREWARE.COM • +49 176 78 5084 19

● Obstructive sleep apnea (OSA) syndrome is the most common organic sleep disorder, characterized by pauses in breathing. ● It may affect children and adults, and result in excessive daytime somnolence and poor performance ● It has been associated with increased frequency of accidents and arterial hypertension ● Continuous positive airway pressure (CPAP) is currently the treatment of choice BACKGROUND Sleep Apnea www.snoreware.com • MARC.FARSSAC@SNOREWARE.COM • +49 176 78 5084 19 • Berlin, 06.02.2015

● About 50% of patients diagnosed with OSA and prescribed CPAP have either not accepted or abandoned CPAP use, often citing discomfort with the apparatus ● Sleep analysis data remains at sleep laboratories and is used only one time to analyse one night PROBLEM www.snoreware.com • MARC.FARSSAC@SNOREWARE.COM • +49 176 78 5084 19 • Berlin, 06.02.2015

● Use patient’s physiological present and past sleep BigData to predict Apneas and personalise a way to avoid them, using wearables and non-invasive mechatronic and / or e-textile devices. SOLUTION SnoreWare www.snoreware.com • MARC.FARSSAC@SNOREWARE.COM • +49 176 78 5084 19 • Berlin, 06.02.2015

BUSINESS MODEL Remote diagnostics & Therapy Value propositions • B2B • Remote diagnostics • Repeatability • Cost & time reduction • Confort • Apnea predict & avoid Therapy (S-REM) • B2C • Consumer self Awareness • Apnea predict & avoid Therapy (S-REM) • Research • Real-time data source • Daily new data • Industry • Promote that industry develops wearables that work with S-REM Customer Relationships • Liaise with research and medical institutions • Liaise with wearable manufacturers Channels • Research • Medical industry • Wearable industry Customer Segments • Diagnostic devices • Therapeutic devices Key partners • Google • Research Institutions • Wearable manufacturers • Sleep laboratories • Health insurances Key activities • Develop SnoreWare • Follow research and pursue results conversion into wearables • Follow industry trends and pursue wearable integration • Seek for vendors of S-REM solutions • Certify Cloud Software Key resources • Implement Software solutions for PSG,Home diagnostics and S-REM with latest Wearables • Vendor qualification (S-REM and wearable) www.snoreware.com • MARC.FARSSAC@SNOREWARE.COM • +49 176 78 5084 19 • Berlin, 06.02.2015

CUSTOMER BENEFITS SnoreWare, Diagnostics & Therapy • Patient • Flexible, user friendly, non-interventional, inexpensive • B2B • Remote diagnostics • Telemedicine: time reduction in diagnostics • Cost reduction for therapy • Analysis repetition from home • Medical R&D • New data available daily • Test new wearables • Particular case: collect and use data for research purposes • Industry • New wearables opportunity -> Data from different w. work together www.snoreware.com • MARC.FARSSAC@SNOREWARE.COM • +49 176 78 5084 19 • Berlin, 06.02.2015

PROJECT HISTORY Dec 2012 - Feb 2015 Dec‘12 Aug‘13 April‘14 Mai’14 Jul’14 Sept‘14 Jan‘15 Feb‘15 FREE Lite Standard Extrem Extrem+ Extrem+ for Wearables Evolution Snorek 1.0 - 1.5 Android 3.3+ Snorek 2.0 Tizen Samsung Gear2 (Tizen O.S) Discontinued Real-time Frontend Sleepwatcher SleepApp 1.0 Android 4.4+ & Wear FREE Full Start Development SnoreWare Medical Industry Full Time Assgnmnt Google Cloud Platform Developer Roadshow Launch Snorek 1.0 Snorek 1.5 (Snore Detection Algorithm 1.5) Samsung Gear2 Challenge Award $2.000 (Notifications) Google App Engine GWT Front End Alfa ~ 1K install / month Remote Diagnostics 1.0 with Google+ SignIn 23 Mai’14 Developer StartUp Pack Android 4.4+ Android Wear, Endpoints GAE, Datastore & Compute Engine with Real-time* Cloud Computing Sept’15 Launch Snorek 2.0 (Snore Detection Algorithm 1.5) Hacked commercial vibration bracelet SEO Activities Jan’15 Heart Rhythm Movement Position Samsung Live Android Wear First level of Snore Warning Simple Artificial intelligence Second level of Snore Warning permitability A. I Medical Sleep feedback Third level of Snore Warning Apnea Prediction and avoidance AI www.snoreware.com • MARC.FARSSAC@SNOREWARE.COM • +49 176 78 5084 19 • Berlin, 06.02.2015

PROJECT EVOLUTION Dec 2012 - Feb 2015 Snorek (2013) • Snore detection • Warns user with an alarm or vibration Sleep App Mobile solution (2014) • Snore detection • Night profile monitor • Snore • Heart Rhythm • Movement & position • Frontend dashboard SnoreWare (2015) • Remote diagnostics PSG (Polysomnography / Home Sleep Studies require certification) • Uses (PSG) wearable data to detect trends, predict apneas and avoid them (Apnea Therapy - requires certification) • System gets better when future new wearables bring new possibilities -> upgrade algorithm • System is scalable to other purposes with data from other wearables • Wakes up user • (“Smart warning” feature is not smart enough) • Self “diagnostics” (B2C) • ! Remote diagnostics (not certified CE/FDA) • UX Usability issues B2C B2C, B2B, Research, Industry (updated Business Plan) Feb 2015 www.snoreware.com • MARC.FARSSAC@SNOREWARE.COM • +49 176 78 5084 19 • Berlin, 06.02.2015

UNDERLYING MAGIC Android Functional sample at Google Play Frontend Functional sample at http://www.sleepapp.de Mechatronics Breathing pause Wearable sensors and e-textiles UNDERLYING MAGIC SnoreWare www.snoreware.com • MARC.FARSSAC@SNOREWARE.COM • +49 176 78 5084 19 • Berlin, 06.02.2015 Vendors

UNDERLYING MAGIC SnoreWare Android Functional sample at Google Play Frontend Functional sample at http://www.sleepapp.de Snorlets (Artificial Intelligence) : Real-time* input-output algorithm, processes data, stores results and returns conclusions to the GAE and then to the client. Different Vendors can have different Snorlets. Used for example for S-REM Apnea prediction Therapy (Silence Rapid Eye Movements). Actions on wearables and mechatronic devices close the loop treating the sleeping person as an input/output system. Wearable sensors and e-textiles Mechatronics Vendors www.snoreware.com • MARC.FARSSAC@SNOREWARE.COM • +49 176 78 5084 19 • Berlin, 06.02.2015 Input / output system Data Storage

CURRENT STATUS & TIMELINE Phase 1: 2015 Introduction Version 1.0 Phase 2: 2016 Diagnostics Version 2.0 Phase 3: 2017 Therapy Version 3.0 Milestones • Project was presented to Sleep Hospital on 09.01. Meeting an interested sleep physician mentor on 17.02 • Meeting with IBB* 11.02 • Founder Team up by 22.03 • “PSG Remote” Functional Sample by Aug. 2015 • Update BP by 22.03 EOB. Launch of commercial activities • “PSG Remote” Prototype by Dec. 2015 Milestones • “PSG Remote” Certification • Commercial activities • Launch PSG Remote Diagnostics (Aug.16) • S-REM Functional Sample by Aug.16 • New sensors qualification Milestones • Certify “S-REM” Therapeutic Apnea Prediction Solution • Office in USA • Deploy therapeutic solution • Continuous improvement and growth www.snoreware.com • MARC.FARSSAC@SNOREWARE.COM • +49 176 78 5084 19 • Berlin, 06.02.2015 *IBB: Investitions Bank Berlin

MARKETING AND SALES • Sleep Apnea study, diagnostics and therapy • Market valued at $19.7 billion* for 2017 and growing • Distribution in 2013: • Diagnostics: 50% • PSG*: 25% • Therapy devices: 20% • Data acquired for research purposes *North America dominated the market in 2013, accounting for approximately 35% of the overall revenue * PSG: Polysomnography, medical sleep study www.snoreware.com • MARC.FARSSAC@SNOREWARE.COM • +49 176 78 5084 19 • Berlin, 06.02.2015 Targets of Phase 1 (2015) & Phase 2 (2016) Target of Phase 3 (2017)

REVENUE MODEL • Licensing model (SnoreWare) • Free during market entry (1.0) - B2C Self awareness • Short-term (2.0 - Diagnostics): self-paying concerned individuals • Midterm (3.0 - Therapy): IGeL service (indiv. health service) • Long-term: Admission to public health care systems • Data for research purposes • System used to capture and supply research data • Additional revenue • Distribution of wearables as qualified distr. partner www.snoreware.com • MARC.FARSSAC@SNOREWARE.COM • +49 176 78 5084 19 • Berlin, 06.02.2015

COMPETITION Traditional Apnea and other breath medical products • ResMed (S+, AirViewTM Patient Management System ResMed-Qualcomm) • Philips Respironics • Others: Weinmann Medical Devices, Natus Medical, Fisher & Paykel Healthcare, DeVilbiss Healthcare, CareFusion • Cloud based clinical software • Brightree Go to the http://www.snoreware.com website. You'll see a link to the Google App Store, taking you to the store and seeing all products we have. Please search for "Sleep www.snoreware.com • MARC.FARSSAC@SNOREWARE.COM • +49 176 78 5084 19 • Berlin, 06.02.2015

Sleep Data Marc Farssac Responsible of all technical aspects of the project, software and hardware TEAM Sleep - Data - Analysis www.snoreware.com • MARC.FARSSAC@SNOREWARE.COM • +49 176 78 5084 19 • Berlin, 06.02.2015 Medical Sleep Analysis Manager Technical Sleep Data Manager Science Data Analysis Manager Sleep Analysis N.N. Medicine Doctor Responsible of all medical aspects of the project, research, test and clinical validation. Data Analysis N.N. Statistician Responsible of all statistical aspects of the project, models, and data validation N.N: Nomen nescio. Appointments planned by 02.03.2015

FINANCE PLAN Phase 1 (2015) • PSG Functional Sample • S-REM Functional Sample • Add industry wearables • Add research institutions • commercial activities • cloud & PSG certification activities Resources • Office and utils • Marketing & Sales dept. • Research & Dev • Medical liaison • Quality Investments (260K) • Office 20K • Marketing & Sales 50K • Research & Dev 100K • Quality 40K • Medical liaison 30K • R&D Lab 20K Phase 2 (2016) • Launch PSG Remote Diagnostics • Start S-REM Therapeutic Solution certification • Expand AI Real-Time computing to other illnesses Resources • Office and utils • Marketing & Sales dept. • Research & Dev. • Medical liaison • Quality • Project Management Investments (500K) • Office and utils 30K • Marketing & Sales 100K • Research & Dev 140K • Medical Liaison 30K • Quality 40K • PSG certification 120K • R&D Lab 40K Phase 3 (2017) • Deploy Therapeutic Solution • Continuous improvement and growth Resources • Office EU & USA • Marketing & Sales • Research & Dev • Project Management • Accounting Investments (1.2M) • Office 100K • Marketing & Sales 300K • Research, Med & Dev 300K • Quality 100K • Certification 250K • R&D Lab 50K www.snoreware.com • MARC.FARSSAC@SNOREWARE.COM • +49 176 78 5084 19 • Berlin, 06.02.2015

FINANCIAL PROJECTION AND KEY METRICS • Sleep Apnea Market valued at $19.7 billion for 2017 and growing • Financial projection and key metrics are currently under revision (u.r). Will be updated by 22.03.2015 EOB. 2015 2016 2017 2018 Penetration Revenue Penetration Revenue Penetration Revenue Penetration Revenue Diagnostic - - u.r % > u.r $ u.r % > u.r $ u.r % > u.r $ Therapy (S-REM) - - - - u.r % >u.r $ u.r % >u.r $ Data for research purposes - - u.r % > u.r $ u.r % > u.r $ u.r % > u.r $ Wearables - - u.r % > u.r $ u.r % > u.r $ u.r % > u.r $ Vendor qualification - - u.r % > u.r $ u.r % > u.r $ u.r % > u.r $ www.snoreware.com • MARC.FARSSAC@SNOREWARE.COM • +49 176 78 5084 19 • Berlin, 06.02.2015